Table 1.
Group demographic and psychosocial measures.
| Measure | Citalopram | Reboxetine | Placebo |
|---|---|---|---|
| (n = 12) |
(n = 13) |
(n = 15) |
|
| Mean (s.d.) | Mean (s.d.) | Mean (s.d.) | |
| Age, years | 25.5 (5) | 26 (3.8) | 25.2 (5) |
| Gender | M = 6, F = 6 | M = 5, F = 8 | M = 7, F = 8 |
| BDI | 2.8 (3.4) | 1.3(1.8) | 1.2 (1.2) |
| TRAIT | 34 (5.9) | 32.6 (7.6) | 31.7 (4.8) |
| FCPS | 126 (13) | 140 (14) | 136.6 (14) |
| SHAPS | 23.7 (4) | 22 (4.8) | 19.9(5.7) |
| BMI | 24.4(3.5) | 21.8(2.3) | 24(2.8) |
BDI, Beck Depression Inventory; FCPS, Fawcett–Clarke Pleasure Scale; SHAPS, Snaith–Hamilton Pleasure Scale; TRAIT, State-Trait anxiety inventory; BMI, Body Mass Index.
One-way ANOVAs all p > 0.06.